Background: Single-needle (SN) dialysis has been accepted as one of the alternative modes of renal replacement therapy. Despite its advantages it is not widely practiced due to the belief of underdialysis by this technique. However, it is used routinely in many hemodialysis units. We therefore aimed to study the efficacy and determine parameters that reflect the dialysis efficiency. The complications and adverse events were also evaluated. The times required to achieve maximal adequacy of dialysis were compared between 4-, 4.5-and 5.0-hour dialysis sessions. Methods: Ten stable end-stage renal disease patients who regularly used the standard hemodialysis technique with double-needle (DN) dialysis were switched to SN dialysis for three consecutive dialysis session times (4, 4.5 and 5.0 h, respectively) for 3 weeks in each period. The following parameters including Kt/V, percent recirculation, calcium, phosphorus, hematocrit, and LDH level were studied at the start and end of each period. Results: After switching to the SN mode, the Kt/V did not change significantly from the baseline value. However, in the subgroup analysis, only the thrice-weekly group achieved the target Kt/V. Kt/V declined insignificantly in the twice-weekly group but did not reach the recommended level. The other parameters were not different from the DN group. The 4-hour group had a similar Kt/V to the other groups and had less recirculation. There were no major complications during the SN phase. The outcome of the fistulas was excellent. Conclusion: The thrice-weekly SN hemodialysis with 4-hour session time has the same efficacy as the conventional DN technique with no more adverse events. Therefore, the SN hemodialysis system may be suitable for routine thrice-weekly hemodialysis in the selected group of patients.

Keywords:
Single-needle dialysis, Adequacy of dialysis
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.